SK Bioscience đầu tư 132 triệu USD mở rộng năng lực sản xuất vaccine

Công ty dược phẩm SK Bioscience Co. của Hàn Quốc ngày 21/6 thông báo kế hoạch đầu tư 150 tỷ won (132 triệu USD) đến năm 2024 để mở rộng năng lực sản xuất vaccine ngừa dịch COVID-19.

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

Bình luận

Xin vui lòng gõ tiếng Việt có dấu

Tin cùng chuyên mục

Chi phí xung đột Israel - Iran vượt 11 tỷ USD

Chi phí xung đột Israel - Iran vượt 11 tỷ USD

Thế giới
(Baothanhhoa.vn) - Theo thông báo của Bộ Tài chính Israel, chi phí từ xung đột giữa Israel và Iran đang gia tăng nhanh chóng, với ước tính chi phí trực tiếp từ xung đột với Iran kể từ cuối tháng 2/2026 đã lên tới khoảng 35 tỷ shekel (tương đương 11,5 tỷ USD).
Chứng nhận tín nhiệm mạng
Việt Long Phần mềm tòa soạn
hội tụ thông minh